Back
Cerevel Therapeutics Holdings Vs. Madrigal Pharmaceuticals Industry Stock Comparison
Buy
55
CERE
Cerevel Therapeutics Holdings
Last Price:
42.28
Seasonality Move:
21.35%
Buy
58
MDGL
Madrigal Pharmaceuticals
Last Price:
207.24
Seasonality Move:
-0.64%
Buy
55
Cerevel Therapeutics Holdings (CERE)
is a Buy
Is Cerevel Therapeutics Holdings a Buy, Sell or Hold?
- The current Cerevel Therapeutics Holdings [CERE] share price is $42.06. The Score for CERE is 55, which is 10% above its historic median score of 50, and infers lower risk than normal.
- CERE is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
58
Madrigal Pharmaceuticals (MDGL)
is a Buy
Is Madrigal Pharmaceuticals a Buy, Sell or Hold?
- The current Madrigal Pharmaceuticals [MDGL] share price is $208.04. The Score for MDGL is 58, which is 16% above its historic median score of 50, and infers lower risk than normal.
- MDGL is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
CERE Stock Price Chart
What is Cerevel Therapeutics Holdings's stock price today?
-
The Cerevel Therapeutics Holdings share price today is $42.06
The current trend is moderately bullish and CERE is experiencing slight selling pressure.
MDGL Stock Price Chart
What is Madrigal Pharmaceuticals's stock price today?
-
The Madrigal Pharmaceuticals share price today is $208.04
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and MDGL is experiencing slight selling pressure.
CERE Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.1 | Buy |
| Relative Strength Index (14 RSI): | 45.76 | Sell |
| Chaikin Money Flow: | -506705 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (41.83 - 42.51) | Sell |
| Bollinger Bands (100): | (41.5 - 42.56) | Buy |
MDGL Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -6.24 | Sell |
| Relative Strength Index (14 RSI): | 42.26 | Sell |
| Chaikin Money Flow: | -21486 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (206.35 - 240.35) | Sell |
| Bollinger Bands (100): | (213.06 - 251.92) | Sell |
CERE Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 42.51 | Sell |
| 20-day SMA: | 42.17 | Sell |
| 50-day SMA: | 42.04 | Buy |
| 200-day SMA: | 33.38 | Buy |
| 8-day EMA: | 42.35 | Sell |
| 20-day EMA: | 42.28 | Sell |
| 50-day EMA: | 41.89 | Buy |
| 200-day EMA: | 36.54 | Buy |
MDGL Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 215.4 | Sell |
| 20-day SMA: | 217.83 | Sell |
| 50-day SMA: | 239.43 | Sell |
| 200-day SMA: | 201.45 | Buy |
| 8-day EMA: | 216.31 | Sell |
| 20-day EMA: | 220.3 | Sell |
| 50-day EMA: | 228.28 | Sell |
| 200-day EMA: | 216.19 | Sell |
Cerevel Therapeutics Holdings Earnings Growth & CERE Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.24 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.14 per share, and a decrease next year of $0.32 per share.
Madrigal Pharmaceuticals Earnings Growth & MDGL Earnings Dates
- Analysts estimate an earnings decrease this quarter of $2.46 per share, an increase next quarter of $1.22 per share, a decrease this year of $8.56 per share, and an increase next year of $10.47 per share.
Cerevel Therapeutics Holdings Technical Analysis
| Apr 25 | Apr 26 | Apr 29 | Apr 30 | May 1 | May 2 | May 3 | May 6 | May 7 | May 8 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr | May | |||||||||
| 25 | 26 | 29 | 30 | 01 | 02 | 03 | 06 | 07 | 08 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Madrigal Pharmaceuticals Technical Analysis
| Apr 25 | Apr 26 | Apr 29 | Apr 30 | May 1 | May 2 | May 3 | May 6 | May 7 | May 8 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr | May | |||||||||
| 25 | 26 | 29 | 30 | 01 | 02 | 03 | 06 | 07 | 08 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||